HDM1005
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Ap
Huadong Medicine · Phase 3 · Not yet recruiting · Enrollment 200
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.